Beam Therapeutics, Inc. (BEAM)
26.92
+0.93
(+3.58%)
USD |
NASDAQ |
Feb 12, 16:00
26.99
+0.07
(+0.26%)
After-Hours: 19:51
Beam Therapeutics Market Cap : 2.732B for Feb. 12, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Intellia Therapeutics, Inc. | 1.348B |
| Pacific Biosciences of California, Inc. | 557.02M |
| Regeneron Pharmaceuticals, Inc. | 82.86B |
| Twist Bioscience Corp. | 2.923B |
| Ionis Pharmaceuticals, Inc. | 13.25B |
Market Cap Related Metrics
| PS Ratio | 45.35 |
| PEG Ratio | -0.0400 |
| Price to Book Value | 2.828 |
| Price | 26.92 |
| Earnings Yield | -16.47% |
| PEGY Ratio | -0.0400 |